Some polymorphisms have been connected to a higher risk of metabolic traits, including T2DM [130,134,135], such as N363S polymorphism [136], while the ER22/23EK polymorphism was associated with reduced first-phase glucose-stimulated insulin secretion [137]. Here, INS is linked to type 2 diabetes mellitus.